ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia"

  • Abstract Number: 1036 • ACR Convergence 2024

    A Pilot Trial of Integrating Patient-Reported Outcome Measurement Information System (PROMIS®) into Rheumatology Care

    Rosemary Gedert1, Danielle Ochocki1, Neda Kortam1, Suiyuan Huang1, Vivek Nagaraja2, Katherine Chakrabarti1, Julia Ford1, Martin Garber1, Jiha Lee1, Vladimir Ognenovski1, David Roofeh3, David Cella4 and Dinesh Khanna1, 1University of Michigan, Ann Arbor, MI, 2Mayo Clinic Arizona, Scottsdale, AZ, 3Rutgers-RWJ Medical School, New Brunswick, NJ, 4Northwestern University, Chicago, IL

    Background/Purpose: Utilizing Patient-Reported Outcomes Measurement Information System (PROMIS®) questionnaires can enhance clinical care by measuring longitudinal changes in symptom severity as reported by the patient.…
  • Abstract Number: 1231 • ACR Convergence 2024

    Exploring Long-term Complications of Lyme Disease – Insights from a Retrospective Cohort Study

    Rafal Ali1, Yurilu Gonzalez Moret2 and Fabian Rodriguez3, 1Jefferson Einstein Philadelphia, Lansdale, PA, 2Jefferson Einstein Philadelphia, Philadelphia, PA, 3Jefferson Einstein Hospital, Philadelphia, PA

    Background/Purpose: Lyme disease is a tick-borne illness with three clinical phases: early localized, early disseminated, and late phase. Other nonspecific symptoms, such as fatigue, body…
  • Abstract Number: 1044 • ACR Convergence 2024

    Analysis of Rheumatic Patients’ Self – Reported Symptoms in Free Written Text Using Natural Language Processing

    Inés Pérez - Sancristóbal1, Nils Steinz2, Ling Qin2, Tjardo Maarseveen3, Floor Zegers4 and Rachel Knevel2, 1Department of Rheumatology, Hospital Clinico San Carlos,, Madrid, Madrid, Spain, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Wormerveer, Netherlands, 4Deparment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Patient-reported symptoms are crucial for medical anamnesis. Digital symptom checkers often use fixed questions, thereby potentially overlooking relevant symptoms. However, the reliability of self-reported…
  • Abstract Number: 1253 • ACR Convergence 2024

    Patterns of Patient-reported Outcome Measures in Patients with Systemic Lupus Erythematosus with or Without Concurrent Fibromyalgia

    Heather Gold1, Yi Li1, Rebecca Anthopolos1, Peter Izmirly2, Jill Buyon1, Mala Masson3, Brooke Cohen1, Kamil Barbour4, Amit Saxena5, H Michael Belmont5, Chung-E Tseng6 and Kelly Corbitt7, 1NYU Grossman School of Medicine, New York, NY, 2New York University Grossman School of Medicine, New York, NY, 3NYU Langone Medical Center- Division of Rheumatology, New York, NY, 4CDC, Alpharetta, GA, 5NYU School of Medicine, New York, NY, 6NYU Langone Health, Flushing, NY, 7University of Miami Miller School of Medicine, El Portal, FL

    Background/Purpose: Patients with SLE often have concomitant FM or symptoms similar to FM, including chronic pain, fatigue, sleep disturbance, and/or depression, potentially distinct from immune-mediated…
  • Abstract Number: 1077 • ACR Convergence 2024

    Pragmatic Quantitative Rheumatologist 0–10 Visual Numeric Scale Estimates of Inflammation, Damage, and Patient Distress Have Face Validity and May Be as Informative as Formal 28 Joint Counts in Rheumatoid Arthritis

    Theodore Pincus1, tengfei Li2 and Juan Schmukler1, 1Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, washington dc

    Background/Purpose: A 28 joint count of swelling (SJC), tenderness/pain on motion (TJC), and deformity/limited motion (DJC), is recommended to assess rheumatoid arthritis (RA) patient status.…
  • Abstract Number: 1323 • ACR Convergence 2024

    Drug Abuse Screening in Patients Who Fulfill the 2016 Fibromyalgia Criteria

    Laura Aline Martinez-Martinez1, Angelica Beltran-Barajas2, Mayra Nadia Quintanar-Cuevas3, David Vera Bustamante4, Itzel Palafox Sosa5, Karyme Zazil Velazquez-Zarza6, Salvador Zuñiga-Roman6 and Luz Angelica Viruel-Mejia7, 1Rheumatology Department - National Institute of Cardiology Ignacio Chavez, Mexico City, Distrito Federal, Mexico, 2Mental health outpatient clinic of the National Institute of Cardiology Ignacio Chavez, Mexico City, 3Mental health outpatient clinic of the National Institute of Cardiology Ignacio Chavez, México, Mexico, 4Benemerita Universidad Autonoma de Puebla, Heroica Puebla de Zaragoza, Puebla, Mexico, 5Escuela Superior de Medicina-Instituto Politecnico Nacional, Ciudad de México, Mexico, 6Mental health outpatient clinic of the National Institute of Cardiology Ignacio Chavez, Mexico City, Distrito Federal, Mexico, 7Rheumatology Departement at National Institute of Cardiology Ignacio Chavez - Universidad Autonoma del Estado de Hidalgo, Tula de Allende, Hidalgo, Mexico

    Background/Purpose: The clinical association of fibromyalgia with symptoms of anxiety and depression is well recognized [Uçar M, et al. J Int Med Res 2015;43(5):679-85]. Emotional…
  • Abstract Number: 1156 • ACR Convergence 2024

    Prevalence and Impact of Fibromyalgia in Patients with Idiopathic Inflammatory Myopathies

    Didem Saygin1, Juan Schmukler2, Kristin Wipfler3, Christopher G McKennan4, Jiaxuan Duan4, Kaleb Michaud5 and Yvonne Lee6, 1Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, Division of Rheumatology, Chicago, IL, 3FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 4University of Pittsburgh, Department of Statistics, Pittsburgh, PA, 5University of Nebraska Medical Center, Omaha, NE, 6Northwestern University, Chicago, IL

    Background/Purpose: Fibromyalgia (FM) is the prototypical central pain disorder that can be associated with rheumatic conditions such as rheumatoid arthritis, Sjogren’s disease and lupus. Patients…
  • Abstract Number: 1520 • ACR Convergence 2024

    The Influence of Trauma on Features of Type 2 SLE

    Jennifer Rogers1, Megan Clowse2, David Pisetsky3, Jayanth Doss4, Mithu Maheswaranathan5, Lisa Criscione-Schreiber5, Rebecca Sadun4, Kai Sun4 and Amanda Eudy6, 1Duke, Durham, NC, 2Duke University, Chapel Hill, NC, 3Duke University Medical Center, Durham, NC, 4Duke University, Durham, NC, 5Duke University School of Medicine, Durham, NC, 6Duke University, Raleigh, NC

    Background/Purpose: Type 2 SLE symptoms of fatigue, widespread pain, sleep and cognitive dysfunction occur commonly in SLE although their etiology is unknown.  Since trauma has…
  • Abstract Number: 1178 • ACR Convergence 2024

    Can Immersive Virtual Reality Improve the Effect of Meditation for People with Fibromyalgia?

    Nancy Baker1, Aliza Spielman1 and Robert Edwards2, 1Tufts University, Medford, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Fibromyalgia (FM) is a common and disabling condition characterized by widespread muscular pain. Meditation has been shown to alleviate affective pain in people with…
  • Abstract Number: 2163 • ACR Convergence 2024

    Predictors of Patient Engagement and Usability in a Chronic Musculoskeletal Pain Management App

    Marc Blanchard1, Cinja Koller2, Patrick Hermann1, Johanna Mettler1, Tiffany Prétat3, Pedro Ming Azevedo3 and Thomas Hügle3, 1Lausanne University Hospital, Lausanne, Vaud, Switzerland, 2Doctoral School, Faculty of Biology and Medicine, University of Lausanne, Genève, Vaud, Switzerland, 3Lausanne University Hospital, Lausanne, Switzerland

    Background/Purpose: Mobile health apps have demonstrated effectiveness in managing chronic musculoskeletal pain syndromes such as fibromyalgia. We developed an app called POCOS for chronic musculoskeletal…
  • Abstract Number: 1212 • ACR Convergence 2024

    Childhood Maltreatment Increases Risk of Chronic Widespread Pain: Counterfactual Analysis of UK Biobank

    Kate Timmins1, Tim Hales2 and Gary Macfarlane1, and The Consortium Against Pain inEquality Investigators and Advisory Group, 1University of Aberdeen, Aberdeen, United Kingdom, 2University of Dundee, Dundee, United Kingdom

    Background/Purpose: Adverse childhood experiences (ACEs), including maltreatment (abuse and neglect), have been associated with chronic pain, but the evidence is largely cross-sectional. Existing evidence is…
  • Abstract Number: 2173 • ACR Convergence 2024

    Hope and Health in Adolescents with Chronic Musculoskeletal Pain

    Irene Chern1, Mackenzie McGill2, Nellie P Butler2 and Sabrina Gmuca2, 1St. Christopher's Hospital for Children, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Hope, the capability to derive pathways to desired goals and motivate oneself via agency thinking plays a protective role in pediatric health contributing to…
  • Abstract Number: 1218 • ACR Convergence 2024

    Randomized, Double-Blind, Placebo-Controlled Confirmatory Phase 3 Trial of Bedtime Sublingual Cyclobenzaprine (TNX-102 SL) in Fibromyalgia

    Seth Lederman1, Lesley Arnold2, Mary Kelley1, Ben Vaughn3, Jean Engels1 and Gregory Sullivan1, 1Tonix Pharmaceuticals, Inc, Chatham, NJ, 2University of Cincinnati College of Medicine, Cincinnati, OH, 3Rho, Inc, Chapel Hill, NC

    Background/Purpose: Fibromyalgia (FM) is a nociplastic syndrome of chronic widespread pain, nonrestorative sleep, fatigue, cognitive dysfunction and mood symptoms. RESILIENT was a confirmatory Phase 3…
  • Abstract Number: 2217 • ACR Convergence 2024

    A Significant Alteration in Circulating Endocannabinoid Levels in Rheumatoid Arthritis and Fibromyalgia Syndrome Patients and Its Correlation with Diseases Severity

    Gilad Halpert1, Eri Govrin2, Boris Gilburd3, Shlomo Segev3, Omer Gendelman4, Abdulla Watad5, Yehuda Shoenfeld6, David Meiri7 and Howard Amital8, 1CAHIM SHEBA MEDICAL CENTER, Tel Hashomer, Israel, 2Sheba Medical Center, Sdot Micha, Israel, 3Sheba Medical Center, Ramat-Gan, Israel, 4Sheba Medical Center, Ramat Gan, Israel, 5Tel Hashomer Medical Center, Ramat Gan, Israel, 6sheba medical center , Israel, Ramat Gan, Israel, 7Technion-Israel Institute of Technology, Haifa, Israel, 8Sheba Medical Center, Tel-Hashomer, Israel, Ramat Gan, Israel

    Background/Purpose: Accumulating evidence suggests that medical cannabis therapy might have beneficial therapeutic effects in the fibromyalgia syndrome (FMS) and in difficult-to-treat rheumatoid arthritis (RA) patients.…
  • Abstract Number: 1219 • ACR Convergence 2024

    Association Between Fibromyalgia and Serum Levels of Calcitonin Gene-Related Peptide and Vascular Endothelial Growth Factor: A Meta-Analysis

    Osama Al Zoubi1, Dahlia Chavez2 and Robert Katz3, 1University of Illinois at Chicago, Chicago, IL, 2Rheumatology Associates, Rush University Medical Center, Chicago, IL, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Fibromyalgia syndrome (FMS) is characterized by generalized muscle pain, fatigue, psychological distress, cognitive dysfunction, and sleep disturbances. The physiopathology of FMS is not fully…
  • 1
  • 2
  • 3
  • …
  • 23
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology